Acknowledgement
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2021R1I1A3055927 to Soh Y), Research Base Construction Fund Support Program funded by Jeonbuk National University in 2021 (Soh Y) and the Ministry of Education, Science and Technology (NRF-2018R1A6A3A11047338 to Yang SY).
References
- Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337-342. https://doi.org/10.1038/nature01658
- Silbermann R, Bolzoni M, Storti P, Guasco D, Bonomini S, Zhou D, et al. Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma. Leukemia. 2014;28(4):951-954. https://doi.org/10.1038/leu.2013.385
- Wu M, Chen W, Lu Y, Zhu G, Hao L, Li YP. Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway. Nat Commun. 2017;8(1):1-13. https://doi.org/10.1038/s41467-016-0009-6
- Zou W, Reeve JL, Liu Y, Teitelbaum SL, Ross FP. DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. Mol Cell. 2008;31(3):422-431. https://doi.org/10.1016/j.molcel.2008.06.023
- Ha H, Kwak HB, Le SW, Kim HH, Lee ZH. Lipid rafts are important for the association of RANK and TRAF6. Exp Mol Med. 2003;35(4):279-284. https://doi.org/10.1038/emm.2003.38
- Zarei A, Morovat A, Javaid K, Brown CP. Vitamin D receptor expression in human bone tissue and dose-dependent activation in resorbing osteoclasts. Bone Res. 2016;4(1):16030. https://doi.org/10.1038/boneres.2016.30
- Liu W, Zhou L, Zhou C, Zhang S, Jing J, Xie L, et al. GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation. Nat Commun. 2016;7(1):12794. https://doi.org/10.1038/ncomms12794
- Wang X, Wei W, Krzeszinski JY, Wang Y, Wan Y. A liver-bone endocrine relay by IGFBP1 promotes osteoclastogenesis and mediates FGF21-induced bone resorption. Cell Metab. 2015;22(5):811-824. https://doi.org/10.1016/j.cmet.2015.09.010
- Su L, Jiang YY, Liu B. Oligopeptides in plant medicines cited in Chinese pharmacopoeia. Zhongguo Zhong Yao Za Zhi. 2016;41(16):2943-2952.
- Yu P, Cheng S, Xiang J, Yu B, Zhang M, Zhang C, et al. Expectorant, antitussive, anti-inflammatory activities and compositional analysis of Aster tataricus. J Ethnopharmacol. 2015;164:328-333. https://doi.org/10.1016/j.jep.2015.02.036
- Ma C, Dastmalchi K, Whitaker BD, Kennelly EJ. Two new antioxidant malonated caffeoylquinic acid isomers in fruits of wild eggplant relatives. J Agric Food Chem. 2011;59(17):9645-9651. https://doi.org/10.1021/jf202028y
- Su XD, Jang HJ, Li HX, Kim YH, Yang SY. Identification of potential inflammatory inhibitors from Aster tataricus. Bioorg Chem. 2019;92:103208. https://doi.org/10.1016/j.bioorg.2019.103208
- Su XD, Jang HJ, Wang CY, Lee SW, Rho MC, Kim YH, et al. Anti-inflammatory potential of saponins from Aster tataricus via NF-κB/MAPK activation. J Nat Prod. 2019;82(5):1139-1148. https://doi.org/10.1021/acs.jnatprod.8b00856
- Sapkota M, Li L, Kim SW, Soh Y. Thymol inhibits RANKL-induced osteoclastogenesis in RAW264.7 and BMM cells and LPS-induced bone loss in mice. Food Chem Toxicol. 2018;120:418-429. https://doi.org/10.1016/j.fct.2018.07.032
- Li L, Sapkota M, Gao M, Choi H, Soh Y. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway. Eur J Pharmacol. 2017;815:202-209. https://doi.org/10.1016/j.ejphar.2017.09.015
- Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell. 1989;58(3):573-581. https://doi.org/10.1016/0092-8674(89)90438-8
- Wu SH, Zhong ZM, Chen JT. Low-magnitude high-frequency vibration inhibits RANKL-induced osteoclast differentiation of RAW264.7 cells. Int J Med Sci. 2012;9(9):801-807. https://doi.org/10.7150/ijms.4838
- Park JH, Lee NK, Lee SY. Current understanding of RANK signaling in osteoclast differentiation and maturation. Mol Cells. 2017;40(10):706-713. https://doi.org/10.14348/molcells.2017.0225
- Boeyens JC, Deepak V, Chua WH, Kruger MC, Joubert AM, Coetzee M. Effects of ω3- and ω6- polyunsaturated fatty acids on RANKL-induced osteoclast differentiation of RAW264.7 cells: a comparative in vitro study. Nutrients. 2014;6(7):2584-2601. https://doi.org/10.3390/nu6072584
- Guo RH, Kim SJ, Choi CH, Na CS, Kang BY, Kim YR. Inhibitory effects of ChondroT and its constituent herbs on RANKL-induced osteoclastogenesis. BMC Complement Altern Med. 2019;19(1):319. https://doi.org/10.1186/s12906-019-2737-8
- Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007;22(10):1479-1491. https://doi.org/10.1359/jbmr.0707onj
- Cheng D, Shao Y. Terpenoid glycosides from the roots of Aster tataricus. Phytochemistry. 1994;35(1):173-176. https://doi.org/10.1016/S0031-9422(00)90528-4
- Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature. 2002;416(6882):744-749. https://doi.org/10.1038/416744a
- Miyamoto T, Suda T. Differentiation and function of osteoclasts. Keio J Med. 2003;52(1):1-7. https://doi.org/10.2302/kjm.52.1
- Lee K, Seo I, Choi MH, Jeong D. Roles of mitogen-activated protein kinases in osteoclast biology. Int J Mol Sci. 2018;19(10):3004. https://doi.org/10.3390/ijms19103004
- Nakamura H, Hirata A, Tsuji T, Yamamoto T. Role of osteoclast extracellular signal-regulated kinase (ERK) in cell survival and maintenance of cell polarity. J Bone Miner Res. 2003;18(7):1198-1205. https://doi.org/10.1359/jbmr.2003.18.7.1198
- Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T, et al. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology. 2002;143(8):3105-3113. https://doi.org/10.1210/en.143.8.3105
- Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003;4(8):638-649. https://doi.org/10.1038/nrg1122
- Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 1994;266(5184):443-448. https://doi.org/10.1126/science.7939685
- Kuroda Y, Matsuo K. Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts. World J Orthop. 2012;3(11):167-174. https://doi.org/10.5312/wjo.v3.i11.167
- Asagiri M, Sato K, Usami T, Ochi S, Nishina H, Yoshida H, et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med. 2005;202(9):1261-1269. https://doi.org/10.1084/jem.20051150
- Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007;7(4):292-304. https://doi.org/10.1038/nri2062
- Ikeda K, Takeshita S. The role of osteoclast differentiation and function in skeletal homeostasis. J Biochem. 2016;159(1):1-8. https://doi.org/10.1093/jb/mvv112
- Kim JH, Kim N. Regulation of NFATc1 in osteoclast differentiation. J Bone Metab. 2014;21(4):233-241. https://doi.org/10.11005/jbm.2014.21.4.233
- Ono T, Nakashima T. Recent advances in osteoclast biology. Histochem Cell Biol. 2018;149(4):325-341. https://doi.org/10.1007/s00418-018-1636-2